Zhou Huayou

[Expert Profile] Zhou Huanyou, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in clinical transfusion and immunohematology in China, working in the Department of Blood Transfusion, Nanfang Hospital, Southern Medical University. He has long been dedicated to clinical diagnosis, treatment, and transfusion safety research of difficult transfusion immune diseases, and is an important expert in the field of transfusion medicine in China.

[Education & Career] Professor Zhou Huanyou graduated from the First Military Medical University (now Southern Medical University), completed systematic clinical training at Nanfang Hospital, and has long been engaged in clinical transfusion and immunohematology work. He has held academic positions in the Transfusion Physicians Branch of the Chinese Medical Doctor Association, and has presided over grants from the National Natural Science Foundation of China and provincial and ministerial research projects, accumulating extensive experience in difficult blood group typing, transfusion immunology, and transfusion safety.

[Areas of Expertise] Professor Zhou specializes in difficult blood group typing, management of cross-matching difficulties, diagnosis and treatment of transfusion immune-related diseases such as autoimmune hemolytic anemia (AIHA), as well as prevention and management of hemolytic disease of the newborn of immune origin during pregnancy. He has extensive experience in rare blood group typing, antibody screening and identification, and development of difficult transfusion plans. He excels at managing difficult cases of "incompatible cross-matching and transfusion difficulties," helping numerous patients with special blood types and difficult transfusion needs receive safe and timely transfusion treatment.

[Academic Achievements & Industry Contributions] Professor Zhou has led a series of clinical studies on difficult transfusion and immunohematology, systematically evaluating diagnosis and treatment strategies for immune hemolytic diseases and transfusion safety technologies, with findings published in authoritative domestic and international journals. He has participated in the development of Chinese clinical transfusion-related guidelines and expert consensus statements, actively promoted the standardization of difficult blood group typing and transfusion compatibility testing techniques, and organized transfusion medicine specialty training and regional collaboration, making important contributions to ensuring clinical blood transfusion safety and improving difficult transfusion diagnosis and treatment levels.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of transfusion medicine clinical work, Professor Zhou has led his team in resolving urgent needs for countless patients with difficult blood types and transfusion difficulties, ensuring the smooth progress of surgery and emergency treatment. He is rigorous and responsible in his work, constantly striving for excellence, and is deeply trusted by clinical departments and patients alike. He has repeatedly organized unpaid blood donation promotion and transfusion safety science popularization, and is a widely respected expert in the field of transfusion medicine.

[Honors & Reputation] Professor Zhou Huanyou serves as Director of the Department of Blood Transfusion at Nanfang Hospital, Southern Medical University and holds academic positions in the Transfusion Physicians Branch of the Chinese Medical Doctor Association. He has presided over grants from the National Natural Science Foundation of China and provincial and ministerial research projects, and is a senior expert in the fields of clinical transfusion and immunohematology in China. He has profound expertise in difficult blood group typing, management of cross-matching difficulties, and diagnosis and treatment of immune hemolytic diseases. He has led the establishment of a multidisciplinary collaboration mechanism for difficult transfusion, promoted the standardization of transfusion compatibility testing and blood safety system construction, and participated in the development of multiple clinical transfusion guidelines. For decades on the clinical front lines, he has resolved urgent needs for numerous patients with difficult blood types and transfusion difficulties, and is deeply trusted by patients and respected by peers alike.